Hemoperfusion in COVID-19
- PMID: 37263252
- DOI: 10.1159/000527583
Hemoperfusion in COVID-19
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global emergency outbreak disease that devastatingly affected world public health and the economy. The pathogenesis of severe SARS-CoV-2 infection in humans has been linked to a strong immunological response that leads to a hyperinflammatory state, or "cytokine storm," which is a sepsis-like state resulting in capillary leakage, microvascular and macrovascular thrombosis, and multiple organ destruction. In recent years, there have been several case series and few randomized controlled trials studying the effectiveness and risk of various hemoperfusion techniques in the context of severe SARS-CoV-2 infection including HA330, CytoSorb, Polymyxin, oXiris, and Seraph 100 cartridges. Because inconsistencies exist between studies, there is currently no consensus regarding the use of hemoperfusion in patients with SARS-CoV-2 infection. Further well-designed research is needed to validate its potential clinical benefits and identify the timing and characteristics of patients who might benefit the most.
© 2023 S. Karger AG, Basel.
Similar articles
-
Literature Review of Hemadsorption Therapy in Severe COVID-19 Cases: a Narrative Review.Clin Lab. 2022 Feb 1;68(2). doi: 10.7754/Clin.Lab.2021.210839. Clin Lab. 2022. PMID: 35142202 Review.
-
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.Blood Purif. 2023;52(1):8-16. doi: 10.1159/000524606. Epub 2022 May 17. Blood Purif. 2023. PMID: 35580567 Free PMC article.
-
Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.Blood Purif. 2022;51(4):317-320. doi: 10.1159/000517430. Epub 2021 Jul 14. Blood Purif. 2022. PMID: 34261058 Free PMC article.
-
[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems].Anaesthesiologie. 2023 Dec;72(12):843-851. doi: 10.1007/s00101-023-01341-w. Epub 2023 Sep 14. Anaesthesiologie. 2023. PMID: 37707564 Review. German.
-
Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry.Nephrol Dial Transplant. 2022 Mar 25;37(4):673-680. doi: 10.1093/ndt/gfab347. Nephrol Dial Transplant. 2022. PMID: 34875087 Free PMC article.
Cited by
-
Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review.J Clin Med. 2024 Jan 5;13(2):317. doi: 10.3390/jcm13020317. J Clin Med. 2024. PMID: 38256451 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous